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Clinical Update
social functioning, a diagnosis of acute stress disor
post-traumatic stress disorder (PTSD) should be con
tures of PTSD are shown in Box 1.
The esti ated 12-month prevalence of PTSD in 
general population is 1.3%, representing around 20
any one year, and the lifetime prevalence rate (the 
people who are diagnosed with the disorder in the120 MJA • Volume 187 NumABSTRACT
• General practitioners have an important role to play in 
helping patients after exposure to severe psychological 
trauma.
• In the immediate aftermath of trauma, GPs should offer 
“psychological first aid”, which includes monitoring of the 
patient’s mental state, providing general emotional support 
and information, and encouraging the active use of social 
support networks, and self-care strategies.
• Drug treatments should be avoided as a preventive 
intervention after traumatic exposure; they may be used 
cautiously in cases of extreme distress that persists.
• Adults with acute stress disorder (ASD) and post-traumatic 
stress disorder (PTSD) should be provided with trauma-
focused cognitive behaviour therapy (CBT). Eye movement 
desensitisation and reprocessing (EMDR) in addition to in-
vivo exposure (confronting avoided situations, people or 
places in a graded and systematic manner) may also be 
provided for PTSD.
• Drug treatments should not normally replace trauma-focused 
psychological therapy as a first-line treatment for adults with 
PTSD.
• If medication is considered for treating PTSD in adults, 
selective serotonin reuptake inhibitor antidepressants are the 
first choice. Other new generation antidepressants and older 
tricyclic antidepressants should be considered as second-line 
pharmacological options. Monoamine oxidase inhibitors may 
be considered by mental health specialists for use in people 
MJA 2007; 187: 120–123
with treatment-resistant symptoms.n A
to 
traI ustralia, about 65% of men and 50% of women are exposeda potentially traumatic event in their lifetime.1,2 Examples ofumatic events include assault and sexual assault, transport
accidents, war, and natural disasters. A degree of psychological
distress is common in the early aftermath of such traumatic




0 000 cases in
percentage of
ir lifetime) is
likely to be about double this figure.1
While a diagnosis of PTSD requires that the symptoms be
present for at least a month, ASD is diagnosed between 2 days and
1 month after a traumatic event. There is significant overlap in the
diagnostic criteria for these conditions. The diagnoses differ in that
ASD requires the experience of several dissociative symptoms not
included in PTSD (such as detachment, reduced awareness of
surroundings and depersonalisation), while PTSD places greater
emphasis on avoidance symptoms by requiring at least three (such
as avoidance of thoughts and feelings about the trauma, avoidance
of activities, places or people that may act as reminders of the
trauma, and passive avoidance symptoms such as emotional
numbing and detachment). A growing body of evidence indicates
that people with ASD are at high risk of developing PTSD.4
However, primarily because of the emphasis on dissociative symp-
toms, about half of people with PTSD do not meet ASD criteria in
the first month after trauma.
In most patients, PTSD is unlikely to present as a stand-alone
problem. Comorbid conditions, including depression, other anxi-
ety disorders, and substance misuse, are common. Associated
problems include relationship difficulties, excessive anger, and
occupational impairment. The clinical recommendations in this article are based on the
recently released evidence-based Australian guidelines for the treat-
ment of adults with acute stress disorder and posttraumatic stress
disorder5 and the United Kingdom PTSD guidelines.6
Screening and assessment in general practice
Traumatic stress problems present to general practitioners in a
variety of ways. Sometimes patients present with expressed con-
cern about their emotional wellbeing after exposure to a traumatic
stressor, and may directly report specific symptoms of ASD or
PTSD. Such presentations are more common after a recent discrete
trauma, such as a motor vehicle accident or an assault. Other
patients may present with a greater focus on related problems,
such as substance misuse, depression or a specific phobic reaction
(such as fear of driving). In such cases, the link to the traumatic
experience may not be explicitly made. However, commonly,
patients with traumatic stress problems present to GPs with
general health complaints, including headaches, gastrointestinal
1 Types of symptoms that characterise post-traumatic 
stress disorder (PTSD)*
Re-experiencing: Intrusive distressing recollections of the traumatic 
event; flashbacks; nightmares; intense psychological distress or 
physical reactions, such as sweating, heart palpitations or panic 
when faced with reminders of the event (one symptom required).
Avoidance and emotional numbing: Avoidance of activities, places, 
thoughts, feelings, or conversations related to the event; restricted 
emotions; loss of interest in normal activities; feeling detached from 
others; psychogenic amnesia; sense of foreshortened future (three 
symptoms required).
Hyperarousal: Difficulty sleeping; irritability; difficulty concentrating; 
hypervigilance; exaggerated startle response (two symptoms 
required).
* Symptoms must be present for at least a month before a diagnosis can be 
made.3 ◆ber 2 • 16 July 2007
CLINICAL UPDATEproblems, rheumatic pains, and skin disorders rather than with
expressed concern about the trauma. Indeed, the traumatic event
may not be mentioned at all. The distress, stigma and potential
shame associated with mental health problems, or with the trauma
itself (such as in cases of sexual assault), may prevent some people
from mentioning the event.
As a result of such difficulties, traumatic stress conditions are
often underdiagnosed in routine clinical settings.7 Thus, GPs
should consider asking, particularly during their assessment of
somatoform or psychosomatic presentations, whether the person
has experienced a traumatic event. If post-traumatic mental health
problems are suspected, a brief screening measure, such as the one
provided in Box 2, should be used to screen for PTSD. Other
useful screening instruments are available from the United States




The following management advice is based on a recent evidence-
based review that analysed the findings of over 69 well controlled
psychological and pharmacological treatment studies. This process
was consistent with National Health and Medical Research Council
(NHMRC) evidence review specifications.9 The NHMRC-approved
Australian guidelines for the treatment of adults with acute stress
disorder and posttraumatic stress disorder5 were developed as a result
of this process. The guidelines, as well as summary versions for
practitioners and consumers, are available at the websites of the
NHMRC (http://www.nhmrc.gov.au/publications/) and the Aus-
tralian Centre for Posttraumatic Mental Health (http://
www.acpmh.unimelb.edu.au).
Management immediately after trauma
Most people experience some level of distress after a traumatic
event, and recover by using their own resources, including their
natural coping strategies and social support networks. Thus,
formal intervention during the first couple of weeks is not
recommended as a routine option, and help should normally be
limited to practical and emotional support tailored to individual
needs. Recommendations for GPs managing patients in the imme-
diate aftermath of trauma are described in Box 3.
Managing ASD and PTSD
In patients whose distress is persistent or severe enough to cause
significant impairment, a diagnosis of ASD or PTSD should be
considered. Thorough clinical assessment should be conducted,
including physical, psychological, social, and occupational func-
tioning, as well as assessment of the risk of self-harm, suicide and
harm to others. An interview with a family member or friend can
be very helpful as part of the assessment process.
PTSD is only one of the potential mental health outcomes after
trauma. Thus, assessment should consider other conditions such
as depression, other anxiety disorders, and substance misuse,
along with the implications for treatment.
A useful self-report measure for assessing PTSD (both initially
and to monitor progress throughout treatment) is the PTSD
checklist,10 described in Box 4.
Treatment for PTSD
The findings of over 58 well controlled psychological and pharma-
cological treatment studies are reviewed in the Australian guide-
lines.5 Implications from these findings are summarised below.
• Adults with PTSD should receive trauma-focused psychological
interventions from appropriately trained mental health practition-
ers. These interventions will usually take the form of cognitive
behaviour therapy (CBT), or eye movement desensitisation and
reprocessing (EMDR) in addition to confronting avoided situa-
tions, people or places in a graded and systematic manner (in-vivo
exposure).
• Key elements of trauma-focused psychological treatment
include:
¾ confronting the traumatic memory in a controlled and safe
environment (imaginal exposure);
¾ identifying, challenging and modifying biased or distorted
thoughts and interpretations about the event and its mean-
ing (cognitive therapy); and
¾ in-vivo exposure.
3 Information for general practitioners managing 
patients in the immediate aftermath of trauma
• “Psychological first aid” should be undertaken. This involves 
ongoing monitoring of the patient’s mental state, providing 
general emotional support, ensuring the patient’s safety and 
security, providing practical assistance and information, and 
encouraging active use of social support mechanisms and self-
care strategies.
• Structured interventions (such as psychological debriefing, with a 
focus on recounting the traumatic event and ventilation of 
feelings) should not be offered on a routine basis. However, 
patients who wish to discuss the experience, and who show a 
capacity to tolerate the associated distress, should be supported 
in doing so. The GP should keep in mind the potential adverse 
effects of excessive ventilation in those who are very distressed or 
have dissociative symptoms.
• Drug treatments should not be used as a preventive intervention 
after exposure to trauma (although they may be used cautiously in 
cases of extreme distress that does not settle, or of severe 
insomnia). ◆
2 Screening questions for post-traumatic stress disorder8
• Do you avoid being reminded of the experience by staying away 
from certain places, people or activities?
• Have you lost interest in activities that were once important or 
enjoyable?
• Have you begun to feel more distant or isolated from other 
people?
• Do you find it hard to feel love or affection for other people?
• Have you begun to feel that there is no point in planning for the 
future?
• Have you had more trouble than usual falling or staying asleep?
• Do you become jumpy or easily startled by ordinary noise or 
movements?
Yes = 1. No = 0. A score of 4 or higher for these seven questions indicates a 
possible diagnosis of post-traumatic stress disorder, with a positive predictive 
value of 71% and a negative predictive value of 98%, based on a community 
sample. ◆MJA • Volume 187 Number 2 • 16 July 2007 121
CLINICAL UPDATE• Drug treatments for PTSD should not normally be used in
preference to trauma-focused psychological therapy as a routine
first-line treatment for adults, either by GPs or by specialist mental
health professionals. However, antidepressant medication may be
considered for the treatment of PTSD in adults if the patient:
¾ is unwilling or unable to engage in trauma-focused psycho-
logical treatment;
¾ is not in a sufficiently stable condition to commence trauma-
focused psychological treatment;
¾ has not gained significant benefit from a trial of trauma-
focused psychological treatment; or
¾ is experiencing severe dissociative symptoms that are likely
to be exacerbated by trauma-focused therapy.
• Where medication is considered for treating PTSD in adults,
selective serotonin reuptake inhibitor (SSRI) antidepressants
should be the first choice for both GPs and mental health
specialists. Although sertraline is the most studied of the SSRIs in
PTSD, it is hard to argue for the superior efficacy of one SSRI over
another.
• Other new generation antidepressants (notably mirtazapine)
and the older tricyclic antidepressants should be considered as a
second-line pharmacological option. Monoamine oxidase inhibi-
tors may be considered for use by mental health specialists for
people with treatment-resistant symptoms.
• When an adult with PTSD has responded to drug treatment, it
should be continued for at least 12 months before gradual
withdrawal.
• Pharmacological interventions should be considered as an
adjunct to psychological treatment where core PTSD or comorbid
symptoms are of sufficient severity to impede benefit from psycho-
logical treatment alone.
• In the context of comorbidity:
¾ When PTSD is comorbid with depression, in most cases, the
PTSD should be treated first, as depression will often
ameliorate as PTSD symptoms reduce. However, when
depressive symptoms prevent effective engagement in treat-
ment or are associated with a high risk of suicide, the
depression should be managed first.
¾ When PTSD is comorbid with substance misuse disorders,
in patients whose level of substance misuse is low-risk to
medium-risk, treat both conditions simultaneously, as the
two are likely to interact to maintain each other. Treatment
may be less effective if either the PTSD or the substance
misuse remains untreated. Substance misuse should be
managed before proceeding to the trauma-focused compo-
nents of PTSD treatment.
Treatment for ASD
If significant symptoms have been present for more than 2 days
but less than a month after trauma, a diagnosis of ASD should be
considered. Compared with the large number of treatment studies
of PTSD, there have been only a small number of high-quality
studies into the psychological and pharmacological treatment of
ASD. If ASD is diagnosed, the patient should be offered individual
trauma-focused CBT, including exposure and/or cognitive therapy.
This treatment should not start until 2 weeks after the traumatic
event. Drug treatments should not be used within 4 weeks of
symptoms appearing unless the severity of the person’s distress
cannot be managed by psychological means alone.
When and why to refer
GPs can do much to assist people recovering from trauma.
Reassurance and support, simple information, and advice on self-
care will often be enough to facilitate a natural recovery process.
However, if the person’s symptoms are severe, and associated with
high levels of prolonged distress, or interfere in social and
occupational functioning, referral to a mental health care provider
(such as a psychiatrist or clinical psychologist) is advisable.
Helping the patient to understand what to expect is an important
component of referral for specialist care. Trauma-focused psycho-
logical treatment (CBT, or EMDR plus in-vivo exposure) can be
expected to reduce the symptoms of PTSD, relieve anxiety and
depression, and improve quality of life. These therapies can also be
effective for people who have experienced prolonged or repeated
traumatic events, although more time to establish a trusting
therapeutic alliance, more attention to teaching emotional regula-
tion skills, and a gradual approach to exposure therapy may be
required in such cases. Interventions that focus purely on reducing
symptoms (such as anxiety management), although not as effective
when used on their own, are useful adjuncts to trauma-focused
treatment. Non-trauma-focused interventions, such as supportive
counselling, should not normally be provided to adults with PTSD.
Specialist pharmacological treatment for PTSD is best managed by
an appropriately experienced psychiatrist, although the continued
involvement of patients’ GPs in the process is strongly recom-
mended.
Unfortunately, research indicates that only a minority of practi-
tioners apply evidence-based treatments for PTSD in their routine
clinical care.13 Thus, when referring patients for specialist psycho-
logical or pharmacological treatment, it would be prudent to
consider whether the specialist practitioner has expertise in evi-
dence-based trauma interventions.
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4 Overview of the post-traumatic stress disorder (PTSD) 
checklist
• The items on the PTSD checklist (PCL) correspond to the 
diagnostic criteria of PTSD in the DSM-IV.11
• Respondents rate each item from 1 (“not at all”) to 5 (“extremely”) 
to indicate the degree to which they have been bothered by that 
particular symptom over the past month.
• A PCL score of 50 has been identified as a useful cut-off for a likely 
diagnosis of PTSD.
• The PCL (and its cut-off score) has been validated against gold-
standard interview measures, both cross-sectionally and in its 
capacity to accurately measure change over time.12
• Health care providers can obtain a copy of the PCL at <http://
www.ncptsd.va.gov/ncmain/assessment/adult_selfreport.jsp> ◆122 MJA • Volume 187 Number 2 • 16 July 2007
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